Compare ENOV & PGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ENOV | PGY |
|---|---|---|
| Founded | 1995 | 2016 |
| Country | United States | United States |
| Employees | N/A | 511 |
| Industry | Fluid Controls | Finance: Consumer Services |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2008 | N/A |
| Metric | ENOV | PGY |
|---|---|---|
| Price | $21.59 | $15.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 8 |
| Target Price | ★ $47.38 | $34.50 |
| AVG Volume (30 Days) | 1.0M | ★ 3.7M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.36 | $14.27 |
| Revenue Next Year | $5.31 | $14.39 |
| P/E Ratio | ★ N/A | $13.54 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $20.55 | $10.40 |
| 52 Week High | $36.82 | $44.99 |
| Indicator | ENOV | PGY |
|---|---|---|
| Relative Strength Index (RSI) | 40.56 | 56.74 |
| Support Level | $21.40 | $10.78 |
| Resistance Level | $27.11 | $16.33 |
| Average True Range (ATR) | 1.20 | 1.19 |
| MACD | -0.19 | 0.10 |
| Stochastic Oscillator | 22.43 | 78.31 |
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
Pagaya Technologies Ltd is a product-focused technology company. It uses machine learning, a vast data network, and an AI-driven approach to offer comprehensive consumer credit and residential real estate products for its partners, their customers, and investors. Its suite of products includes Decline Monetization, Dual Look, First Look, Affiliate Optimizer Engine, Direct Marketing Engine, and FastPass, providing lenders with an AI-powered credit and acquisition ecosystem that helps them approve more borrowers, capture more demand, and grow without adding risk. Geographically, the company generates maximum revenue from its business in the United States.